ATE246706T1 - Verwendung einer sulfamat-ester enthaltenden sterolverbindung zur herstellung eines arzneimittels zur kontrolle der östrogenproduktion - Google Patents

Verwendung einer sulfamat-ester enthaltenden sterolverbindung zur herstellung eines arzneimittels zur kontrolle der östrogenproduktion

Info

Publication number
ATE246706T1
ATE246706T1 AT99203449T AT99203449T ATE246706T1 AT E246706 T1 ATE246706 T1 AT E246706T1 AT 99203449 T AT99203449 T AT 99203449T AT 99203449 T AT99203449 T AT 99203449T AT E246706 T1 ATE246706 T1 AT E246706T1
Authority
AT
Austria
Prior art keywords
sub
compound
sulfamat
ester
producing
Prior art date
Application number
AT99203449T
Other languages
German (de)
English (en)
Inventor
Michael John Reed
Barry Victor Lloyd Potter
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Application granted granted Critical
Publication of ATE246706T1 publication Critical patent/ATE246706T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Surgical Instruments (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99203449T 1991-08-29 1992-08-28 Verwendung einer sulfamat-ester enthaltenden sterolverbindung zur herstellung eines arzneimittels zur kontrolle der östrogenproduktion ATE246706T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919118478A GB9118478D0 (en) 1991-08-29 1991-08-29 Steroid sulphatase inhibitors

Publications (1)

Publication Number Publication Date
ATE246706T1 true ATE246706T1 (de) 2003-08-15

Family

ID=10700604

Family Applications (5)

Application Number Title Priority Date Filing Date
AT99203449T ATE246706T1 (de) 1991-08-29 1992-08-28 Verwendung einer sulfamat-ester enthaltenden sterolverbindung zur herstellung eines arzneimittels zur kontrolle der östrogenproduktion
AT00204525T ATE278704T1 (de) 1991-08-29 1992-08-28 Estran- sulphamatederivaten als steroid-sulfatase hemmende verbindungen
AT92918285T ATE194843T1 (de) 1991-08-29 1992-08-28 Verwendung von sulphamatederivaten als steroid- sulfatase hemmende verbindungen
AT98204337T ATE237333T1 (de) 1991-08-29 1992-08-28 Pharmazeutische mischungen, enthaltend sulphamatderivate als steroidsulfatasehemmende verbindungen
AT98204340T ATE239753T1 (de) 1991-08-29 1992-08-28 Steroid-sulfatase hemmende verbindungen

Family Applications After (4)

Application Number Title Priority Date Filing Date
AT00204525T ATE278704T1 (de) 1991-08-29 1992-08-28 Estran- sulphamatederivaten als steroid-sulfatase hemmende verbindungen
AT92918285T ATE194843T1 (de) 1991-08-29 1992-08-28 Verwendung von sulphamatederivaten als steroid- sulfatase hemmende verbindungen
AT98204337T ATE237333T1 (de) 1991-08-29 1992-08-28 Pharmazeutische mischungen, enthaltend sulphamatderivate als steroidsulfatasehemmende verbindungen
AT98204340T ATE239753T1 (de) 1991-08-29 1992-08-28 Steroid-sulfatase hemmende verbindungen

Country Status (25)

Country Link
US (3) US5616574A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (6) EP0921130B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (6) JP3219408B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (4) KR100258396B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (5) ATE246706T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU689043B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9206434A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (4) CA2305749A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (4) CY2253B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ295939B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (5) DE69233149T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (4) DK0982032T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (4) ES2196483T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (5) FI940903A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB9118478D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GE (6) GEP20033094B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3034579T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUT66097A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LV (1) LV12618B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (6) NO307301B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (4) RU2207134C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (7) SG103374A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (4) SK282186B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (4) UA41875C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1993005064A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
US6903084B2 (en) 1991-08-28 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
GB9604709D0 (en) * 1996-03-05 1996-05-01 Imperial College A compound
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6011024A (en) * 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
ES2201101T3 (es) * 1994-04-05 2004-03-16 Celltech Therapeutics Limited Uso de inhibidores de sulfatasas de esteroides.
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4447714C2 (de) * 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur Hormonsubstitutions-Therapie
GB9422777D0 (en) * 1994-11-11 1995-01-04 Imperial College Assay
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5705495A (en) * 1995-10-19 1998-01-06 Jenapharm Gmbh & Co. Kg. Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds
US6921776B1 (en) 1996-02-16 2005-07-26 Sterix Limited Compound
US6506792B1 (en) 1997-03-04 2003-01-14 Sterix Limited Compounds that inhibit oestrone sulphatase and/or aromatase and methods for making and using
EP0885211B1 (en) * 1996-03-05 2004-12-29 Sterix Limited Compounds with a sulfamate group
KR20000035979A (ko) * 1996-09-12 2000-06-26 야마구찌 다까시 3-치환-ｄ-호모-1,3,5(10)-에스트라트리엔 유도체
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
US6642220B1 (en) * 1996-12-05 2003-11-04 Sterix Limited Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same
US5763432A (en) * 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
DE19712488A1 (de) 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
GB9708716D0 (en) * 1997-04-29 1997-06-18 Imperial College Chronic heart failure
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6376687B1 (en) 1997-07-18 2002-04-23 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
GB2331987B (en) * 1997-12-04 2002-11-27 Imperial College Polycyclic sulphamate inhibitors of oestrone sulphatase
GB2331988B (en) 1997-12-04 2003-04-16 Imperial College Polycyclic sulphamate inhibitors or oestrone sulphatase
US6046186A (en) * 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
DE69942578D1 (de) 1998-05-22 2010-08-26 Univ R Bifunktionelle moleküle sowie darauf basierende therapien.
EP1085876B1 (en) * 1998-06-10 2008-07-23 Sterix Limited Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
WO2000053620A1 (fr) * 1999-03-10 2000-09-14 Nippon Organon K. K. Nouveaux derives d'oestradiol
JP2000309599A (ja) 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
JP5042411B2 (ja) 1999-04-30 2012-10-03 ステリックス リミテッド 抗腫瘍剤としてのエストロン誘導体の使用
AU2005225148B2 (en) * 1999-04-30 2008-04-03 Sterix Limited Use
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
US6583130B1 (en) 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
EP1237902B1 (en) * 1999-12-13 2005-11-02 Sterix Limited Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
JPWO2001081364A1 (ja) * 2000-04-24 2004-01-08 協和醗酵工業株式会社 エストラ−１，３，５（１０）−トリエン誘導体
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
JP2004521951A (ja) * 2001-07-13 2004-07-22 シエーリング アクチエンゲゼルシャフト Ｈｒｔのためのドロスピレノン及びエストロゲンスルファメートの組み合わせ
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
DE10139494A1 (de) * 2001-08-13 2003-03-06 Jenapharm Gmbh Antitumor wirksame 2-Alkoxyestradiolsulfamate
EP1657247B1 (en) 2001-10-18 2008-09-17 Sterix Limited Steroidal compounds for inhibiting steroid sulphotase
EP1448592B1 (en) * 2001-10-18 2006-03-08 Sterix Limited Steroidal compounds for inhibiting steroid sulphatase
US20040254241A1 (en) * 2002-08-28 2004-12-16 Yoji Ino Aryl sulfamate derivatives
EP1568381A1 (en) * 2002-10-09 2005-08-31 Kyowa Hakko Kogyo Co., Ltd. Remedy for hormone-dependent cancer
DE10307105A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
DE10307103A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
DE10307104A1 (de) 2003-02-19 2004-09-23 Schering Ag Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
AU2003260390B2 (en) * 2003-05-16 2010-05-20 Laboratoire Theramex Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors
EP1627871B1 (en) 2003-05-21 2010-04-14 ASKA Pharmaceutical Co., Ltd. Cyclic aminophenyl sulfamate derivative
TWI331154B (en) * 2003-11-12 2010-10-01 Solvay Pharm Gmbh Novel 17-hydroxysteroid dehydrogenase type i inhibitors
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
ES2528403T3 (es) 2005-04-28 2015-02-09 Proteus Digital Health, Inc. Sistemas informáticos farmacéuticos
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
GB0624105D0 (en) * 2006-12-01 2007-01-10 Sterix Ltd Use
GB0706072D0 (en) 2007-03-28 2007-05-09 Sterix Ltd Compound
EP2207544A2 (en) 2007-09-17 2010-07-21 PregLem S.A. Treatment of oestrogen dependant conditions in pre-menopausal women
EP2149371A1 (en) * 2008-07-28 2010-02-03 PregLem S.A. Use of steroid sulfatase inhibitors for the treatment of preterm labor
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
CN110974840A (zh) * 2019-12-27 2020-04-10 天津市肿瘤医院 一种类固醇硫酸酯酶抑制剂及其药物用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE114806C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) *
DE1593846A1 (de) * 1967-01-28 1971-02-25 Hoechst Ag Verfahren zur Herstellung von Sulfamidsaeure-arylestern
US3647738A (en) * 1970-11-03 1972-03-07 Union Carbide Corp Alpha-olefin polymer compositions
GB1398026A (en) * 1972-11-10 1975-06-18 Jenapharm Veb Steroid esters
DE2418217A1 (de) * 1974-04-13 1975-11-06 Hoechst Ag Sulfamidsaeureester und verfahren zu ihrer herstellung
DD114806A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1974-10-11 1975-08-20
US4340602A (en) * 1978-10-18 1982-07-20 Wayne State University Compositions inhibiting estrogen sulfotransferase activity
US4810700A (en) * 1978-10-18 1989-03-07 Wayne State University Compositions inhibiting estrogen sulfotransferase activity
US4937237A (en) * 1988-12-23 1990-06-26 Smithkline Beckman Corporation Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase
PT94305B (pt) * 1989-06-12 1997-02-28 Robins Co Inc A H Processo para a preparacao de compostos tendo um ou mais radicais aminossulfoniloxi uteis como produtos farmaceuticos
GB9003939D0 (en) * 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
GB9118465D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19540233B4 (de) * 1995-10-19 2005-08-25 Schering Ag Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP0885211B1 (en) * 1996-03-05 2004-12-29 Sterix Limited Compounds with a sulfamate group
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same

Also Published As

Publication number Publication date
CY2394B1 (en) 2004-09-10
DE69233149T2 (de) 2004-06-24
EP1099706B1 (en) 2004-10-06
GB9118478D0 (en) 1991-10-16
SK282186B6 (sk) 2001-12-03
DE69233053T2 (de) 2003-11-20
BR9206434A (pt) 1994-09-27
DE69233020T2 (de) 2003-11-06
CA2114630C (en) 2003-09-30
JP2000038341A (ja) 2000-02-08
SK282187B6 (sk) 2001-12-03
AU689043B2 (en) 1998-03-19
RU2182152C2 (ru) 2002-05-10
FI20002261A7 (fi) 2000-10-13
FI940903A7 (fi) 1994-04-20
EP0641355B1 (en) 2000-07-19
KR100322650B1 (ko) 2002-03-20
HK1025051A1 (en) 2000-11-03
EP1099706A2 (en) 2001-05-16
JP3581802B2 (ja) 2004-10-27
GEP20022766B (en) 2002-08-26
FI940903A0 (fi) 1994-02-25
US5830886A (en) 1998-11-03
CY2253B1 (en) 2003-07-04
DE69233020D1 (de) 2003-05-22
EP0928609A2 (en) 1999-07-14
CZ44094A3 (en) 1995-01-18
DE69233149D1 (de) 2003-09-11
EP0928609B1 (en) 2003-04-16
ES2196483T3 (es) 2003-12-16
DK0921130T3 (da) 2003-07-21
ES2193475T3 (es) 2003-11-01
AU5837396A (en) 1996-09-05
EP1099706A3 (en) 2002-09-04
EP0921130B1 (en) 2003-05-07
US6159960A (en) 2000-12-12
RU94019334A (ru) 1996-10-20
UA70958C2 (uk) 2004-11-15
NO318009B1 (no) 2005-01-17
EP1522543A1 (en) 2005-04-13
WO1993005064A1 (en) 1993-03-18
CA2305749A1 (en) 1993-03-18
ES2148178T3 (es) 2000-10-16
SG88782A1 (en) 2002-05-21
NO307301B1 (no) 2000-03-13
AU717116B2 (en) 2000-03-16
FI20050991A7 (fi) 2005-10-03
EP0928609A3 (en) 2001-11-07
CA2114630A1 (en) 1993-03-18
KR100321018B1 (ko) 2002-03-20
HK1020672A1 (en) 2000-05-19
GEP20022803B (en) 2002-09-25
DK0928609T3 (da) 2003-07-21
ATE237333T1 (de) 2003-05-15
NO995075D0 (no) 1999-10-18
DK0982032T3 (da) 2003-11-03
NO940635L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-04-29
CY2397B1 (en) 2004-09-10
SG103374A1 (en) 2004-04-29
DE69231280T2 (de) 2000-11-30
GEP20063773B (en) 2006-03-27
GEP20033094B (en) 2003-10-27
EP0982032A3 (en) 2002-03-20
HK1019753A1 (en) 2000-02-25
NO940635D0 (no) 1994-02-24
AU668882B2 (en) 1996-05-23
DE69233431D1 (de) 2004-11-11
DK0641355T3 (da) 2000-10-09
JP3581821B2 (ja) 2004-10-27
KR100321019B1 (ko) 2002-03-20
NO995076L (no) 1994-04-29
DE69233053D1 (de) 2003-06-12
NO308903B1 (no) 2000-11-13
FI20050991L (fi) 2005-10-03
RU2210574C2 (ru) 2003-08-20
FI20002259A7 (fi) 2000-10-13
HUT66097A (en) 1994-09-28
SG73391A1 (en) 2006-08-30
SK282189B6 (sk) 2001-12-03
ES2204059T3 (es) 2004-04-16
FI20002260L (fi) 2000-10-13
SG103820A1 (en) 2004-05-26
EP0921130A2 (en) 1999-06-09
EP0641355A1 (en) 1995-03-08
US5616574A (en) 1997-04-01
NO995075L (no) 1994-04-29
CA2305767A1 (en) 1993-03-18
HU9400583D0 (en) 1994-05-30
ATE239753T1 (de) 2003-05-15
AU2490592A (en) 1993-04-05
EP0982032B1 (en) 2003-08-06
CA2305758A1 (en) 1993-03-18
NO20025725D0 (no) 2002-11-28
JP2000355542A (ja) 2000-12-26
KR100258396B1 (ko) 2000-08-01
SG106116A1 (en) 2004-09-30
FI20002259L (fi) 2000-10-13
NO20025725L (no) 1994-04-29
NO20044458L (no) 1994-04-29
ATE194843T1 (de) 2000-08-15
NO314287B1 (no) 2003-03-03
NO2595A (no) 1994-04-29
SK282188B6 (sk) 2001-12-03
RU2001125673A (ru) 2003-06-27
FI20002261L (fi) 2000-10-13
ATE278704T1 (de) 2004-10-15
DE69231280D1 (de) 2000-08-24
SG88783A1 (en) 2002-05-21
EP0921130A3 (en) 2001-09-05
GR3034579T3 (en) 2001-01-31
NO995076D0 (no) 1999-10-18
JP2002255993A (ja) 2002-09-11
DE69233431T2 (de) 2006-02-23
FI20002260A7 (fi) 2000-10-13
JP3581820B2 (ja) 2004-10-27
SG115508A1 (en) 2005-10-28
LV12618B (en) 2001-07-20
EP0982032A2 (en) 2000-03-01
LV12618A (en) 2001-02-20
GEP20022802B (en) 2002-09-25
AU1007799A (en) 1999-03-04
UA41875C2 (uk) 2001-10-15
RU2207134C2 (ru) 2003-06-27
GEP20022637B (en) 2002-02-25
JP2000355598A (ja) 2000-12-26
NO20002595D0 (no) 2000-05-19
JP3219408B2 (ja) 2001-10-15
CY2398B1 (en) 2004-09-10
UA70956C2 (uk) 2004-11-15
CZ295939B6 (cs) 2005-12-14
SK24694A3 (en) 1994-11-09
NO308774B1 (no) 2000-10-30
UA70957C2 (uk) 2004-11-15
JPH07501515A (ja) 1995-02-16
JP2003176297A (ja) 2003-06-24

Similar Documents

Publication Publication Date Title
ATE246706T1 (de) Verwendung einer sulfamat-ester enthaltenden sterolverbindung zur herstellung eines arzneimittels zur kontrolle der östrogenproduktion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0982032

Country of ref document: EP

REN Ceased due to non-payment of the annual fee